INDP icon

Indaptus Therapeutics

17 hedge funds and large institutions have $750K invested in Indaptus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
5
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$318K 256,265
IHL
2
Investment House LLC
California
$124K 99,976 -2,461 -2%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$90.7K 73,129 +13,820 +23%
SAM
4
Strategy Asset Managers
California
$56.2K 45,336
PVI
5
Pine Valley Investments
New Jersey
$54.5K 43,983 -102 -0.2%
Renaissance Technologies
6
Renaissance Technologies
New York
$33.6K 27,100 +500 +2%
VCM
7
Vivaldi Capital Management
Illinois
$29.8K 24,000
Citadel Advisors
8
Citadel Advisors
Florida
$19.1K 15,390 -6,820 -31%
State Street
9
State Street
Massachusetts
$16.2K 13,073
TRCT
10
Tower Research Capital (TRC)
New York
$5.97K 4,812 +710 +17%
Morgan Stanley
11
Morgan Stanley
New York
$1.1K 884
UBS Group
12
UBS Group
Switzerland
$647 522 -170 -25%
BSB
13
Bangor Savings Bank
Maine
$496 400
Wells Fargo
14
Wells Fargo
California
$79 64
Bank of America
15
Bank of America
North Carolina
$74 60 +18 +43%
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$24 19 +4 +27%
Group One Trading
17
Group One Trading
Illinois
$9 7
BHWM
18
Beaird Harris Wealth Management
Texas
-300 Closed
Fidelity Investments
19
Fidelity Investments
Massachusetts
-79 Closed
MPWT
20
MassMutual Private Wealth & Trust
Connecticut
-14 Closed
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
-1 -100%
CFGS
22
Concourse Financial Group Securities
Alabama